Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 657 | $430,299,687 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 4 | 816.52 | 3,266 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 3 | 815.46 | 2,446 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 1 | 814.78 | 815 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 4 | 813.35 | 3,253 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 3 | 812.58 | 2,438 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 27 | 811.48 | 21,910 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 7 | 810.77 | 5,675 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 1 | 809.03 | 809 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 184 | 821.46 | 151,149 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 345 | 820.54 | 283,086 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 973 | 819.57 | 797,442 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 1,333 | 818.59 | 1,091,180 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 1,881 | 817.36 | 1,537,454 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 829 | 816.46 | 676,845 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 58 | 814.06 | 47,215 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 155 | 815.97 | 126,475 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 167 | 813.66 | 135,881 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 372 | 812.57 | 302,276 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 103 | 811.37 | 83,571 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 136 | 810.38 | 110,212 | D |
12 Dec 2023 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 11 Dec 2023 | Sale | 270 | 838.44 | 226,379 | D |
14 Dec 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 13 Dec 2023 | Sale | 610 | 870 | 530,700 | D |
26 Dec 2023 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Controller | 22 Dec 2023 | Sale | 250 | 846.27 | 211,568 | D |
26 Dec 2023 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Controller | 21 Dec 2023 | Sale | 1,224 | 844.09 | 1,033,166 | D |
26 Dec 2023 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Controller | 21 Dec 2023 | Sale | 456 | 843.79 | 384,768 | D |
29 Dec 2023 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Controller | 27 Dec 2023 | Sale | 2,448 | 856.71 | 2,097,226 | D |
29 Dec 2023 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 27 Dec 2023 | Sale | 2,049 | 898 | 1,840,002 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 3 | 904.49 | 2,713 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 13 | 903.49 | 11,745 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 10 | 902.37 | 9,024 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 9 | 901.46 | 8,113 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 29 | 900.59 | 26,117 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 14 | 899.66 | 12,595 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 6 | 898.76 | 5,393 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 3 | 897.41 | 2,692 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 8 | 896.47 | 7,172 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 1 | 892 | 892 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 1 | 887.13 | 887 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 2 | 886.26 | 1,773 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 1 | 873.91 | 874 | D |
04 Jan 2024 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | ZOGHBI HUDA Y | Director | 02 Jan 2024 | Sale | 1,117 | 900 | 1,005,300 | D |
04 Jan 2024 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 03 Jan 2024 | Sale | 826 | 914 | 754,964 | D |
04 Jan 2024 16:17 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 02 Jan 2024 | Sale | 274 | 873.91 | 239,451 | D |
04 Jan 2024 16:20 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 02 Jan 2024 | Sale | 16,848 | 900 | 15,163,200 | I |
25 Jan 2024 16:18 | REGN | REGENERON PHARMACEUTICALS Inc | GOLDSTEIN JOSEPH L | Director | 23 Jan 2024 | Sale | 2,707 | 950 | 2,571,650 | D |
31 Jan 2024 16:52 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 30 Jan 2024 | Sale | 827 | 959 | 793,093 | D |
02 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Feb 2024 | Sale | 273 | 945.61 | 258,152 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 4 | 963.73 | 3,855 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 6 | 962.49 | 5,775 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 4 | 961.37 | 3,845 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 10 | 960.52 | 9,605 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 8 | 959.68 | 7,677 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 5 | 958.65 | 4,793 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 3 | 957.75 | 2,873 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 7 | 956.21 | 6,693 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 10 | 955.35 | 9,554 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 3 | 953.18 | 2,860 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 5 | 954.52 | 4,773 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 3 | 951.4 | 2,854 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 2 | 950.01 | 1,900 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 10 | 949.48 | 9,495 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 3 | 947.37 | 2,842 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 1 | 948.77 | 949 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 1 | 944.66 | 945 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 3 | 943.54 | 2,831 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 5 | 942.5 | 4,712 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 6 | 941.91 | 5,651 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 1 | 939.53 | 940 | D |
06 Feb 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 05 Feb 2024 | Sale | 1,000 | 934.71 | 934,710 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 19 | 953 | 18,107 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 1,059 | 952.49 | 1,008,687 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 1,237 | 951.49 | 1,176,993 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 3,127 | 950.43 | 2,971,995 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 601 | 949.45 | 570,619 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 1,894 | 948.69 | 1,796,819 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 100 | 947.34 | 94,734 | D |
09 Feb 2024 16:12 | REGN | REGENERON PHARMACEUTICALS Inc | LAROSA JOSEPH J | EVP General Counsel and Secret | 07 Feb 2024 | Sale | 1,000 | 950 | 950,000 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 600 | 955 | 573,000 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 1,100 | 954.57 | 1,050,027 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 1,342 | 953.47 | 1,279,557 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 1,046 | 952.62 | 996,441 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 487 | 951.39 | 463,327 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 344 | 950.49 | 326,969 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 09 Feb 2024 | Sale | 500 | 955 | 477,500 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 08 Feb 2024 | Sale | 500 | 945 | 472,500 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 200 | 951.77 | 190,354 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 375 | 950.45 | 356,419 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 112 | 949.07 | 106,296 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 150 | 948.7 | 142,305 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 240 | 947.81 | 227,474 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 95 | 945.81 | 89,852 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 620 | 944.3 | 585,466 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 2,691 | 943.51 | 2,538,985 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 275 | 941.41 | 258,888 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 750 | 939.6 | 704,700 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 4,261 | 940.44 | 4,007,215 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 226 | 938.13 | 212,017 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 439 | 937.94 | 411,756 | D |
26 Feb 2024 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 23 Feb 2024 | Sale | 500 | 985 | 492,500 | D |
26 Feb 2024 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 22 Feb 2024 | Sale | 1,000 | 960 | 960,000 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)